tradingkey.logo

CAMP4 Therapeutics Corp

CAMP

1.640USD

-0.010-0.61%
Close 08/04, 16:00ETQuotes delayed by 15 min
33.06MMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2023Q4
FY2023Q3
Total revenue
--858.00K
--652.00K
-100.00%0.00
--0.00
--350.00K
Revenue
--858.00K
--652.00K
-100.00%0.00
--0.00
--350.00K
Operating expenses
--13.96M
8.98%14.69M
6.53%13.52M
--13.48M
--12.69M
R&D expenses
--10.15M
-6.24%10.00M
-1.19%9.70M
--10.66M
--9.82M
Depreciation, depletion, and amortization
--421.00K
808.70%418.00K
-2.79%418.00K
--46.00K
--430.00K
Operating profit
---13.10M
-4.14%-14.03M
-9.55%-13.52M
---13.48M
---12.34M
Net non-operating interest income (expenses)
Non-operating interest income
--588.00K
7.21%610.00K
-86.36%94.00K
--569.00K
--689.00K
Non-operating interest expense
--3.00K
--4.00K
-40.00%6.00K
----
--10.00K
Gains from sale of securities
----
--4.00K
-40.00%6.00K
----
--10.00K
Other non-operating income (expenses)
--82.00K
274.70%145.00K
-31.91%-62.00K
---83.00K
---47.00K
Income before tax
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Income tax
--0.00
--0.00
----
----
----
Income after tax
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Net income from continuous operations
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Net income attributable to controlling interests
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Net income attributable to common shareholders
---12.43M
-2.22%-13.28M
-15.29%-13.48M
---12.99M
---11.70M
Basic earnings per share
---0.62
-2.23%-0.68
-15.29%-0.69
---0.67
---0.60
Diluted earnings per share
---0.62
-2.23%-0.68
-15.29%-0.69
---0.67
---0.60
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
KeyAI